Clinical realities and economic considerations: Special therapeutic issues in intrathecal therapy—tolerance and addiction
Open Access
- 1 September 1997
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 14 (3) , S27-S35
- https://doi.org/10.1016/s0885-3924(97)00168-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiologyJournal of Neurosurgery, 1996
- Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: A case studyArchives of Physical Medicine and Rehabilitation, 1996
- Opioid therapy for chronic nonmalignant pain: a review of the critical issuesJournal of Pain and Symptom Management, 1996
- Long-Term Intrathecal Administration of Midazolam and ClonidineThe Clinical Journal of Pain, 1996
- Intraspinal morphine for chronic pain: A retrospective, multicenter studyJournal of Pain and Symptom Management, 1996
- Addiction in the treatment of pain: Significance, recognition, and managementJournal of Pain and Symptom Management, 1993
- Myoclonic Seizure Activity with Chronic High-Dose Spinal Opioid AdministrationAnesthesiology, 1990
- Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physiciansPain, 1987
- Management of pain during debridement: a survey of U.S. burn unitsPain, 1982
- Addiction Rare in Patients Treated with NarcoticsNew England Journal of Medicine, 1980